banner

Comprehensive Newborn
Screening Test

Comprehensive
Newborn Screening
Test

Provide more healthy future for your child
by detecting treatable diseases early

Provide more healthy future
for your child by detecting
treatable diseases early

$650

Buy

Go beyond with
comprehensive testing

Go beyond with
comprehensive testing

icon

Severe symptoms or illness in newborns can be due to rare changes in the child’s genetic makeup which occur before they are born . These changes can produce complex, often life-threatening conditions affecting one or more regions of the body, such as skin, heart, lungs, muscle, bones, blood system or the body’s metabolism. The severity and outcome for the child can vary dramatically.

SZA Longevity Comprehensive Newborn Screening Test uses Whole-genome sequencing (WGS) which enables examination of the entire DNA sequence of the genome, both the coding and non-coding nuclear sequence as well as the mitochondrial sequence. WGS can evaluate SNVs, indels, non-coding regions, mitochondrial variants, all sizes of CNVs and structural rearrangements.

This test is not only for your baby’s early-onset conditions, but it also generates the whole genome data of him/her which can be used for further analysis to uncover adult-onset conditions. You will have the option to learn additional information including low or no actionability childhood-onset conditions, high actionability adult-onset conditions, and carrier status for recessive disorders.

icon icon If you need a basic analysis, covering the variants found only in the coding region of genes, you can check our Whole Exome sequencing based Basic Newborn Screening Test.

Up to date analysis
and reporting

Up to date analysis
and reporting

icon

SZA Longevity Comprehensive Newborn Screening Test identifies DNA changes that could cause severe or life-altering symptoms in an infant. This analysis includes 1054 genes and assesses over 1200 disorders, covering many conditions beyond any legislated standards for newborn screening.

icon icon You can learn more about screened genes and related disorders here:
Genes Included on SZA Longevity Comprehensive Newborn Screening Test

Given the fast pace of gene discovery, it is important to realize the need to thoroughly reanalyze WGS results. The rationale behind a reexamination of the same data after a significant amount of time has passed is that the number of gene-disease associations has improved and thus the likelihood of identifying additional results is increased . With SZA Longevity Comprehensive Newborn Screening Test, you will have the control of your baby’s genome data so you can request re-analysis every 2 years with the updated database.

icon icon You can learn more about WGS based testing here.

How it works?

icon
icon

1Order your sample collection kit

icon

2Collect your sample as instructed

icon

3Fill out a Consent form provided
with your kit

icon

4Send sample & paperwork to SZA Longevity for processing

icon

5Get your report within 2 - 3 weeks

icon

6Share & discuss your results
with your healthcare provider

Actionable and
Well-defined Results

icon

Our reports always contain well-defined actionable results, recommendations, and follow-up options. They are phenotype-driven and focused on reporting findings related to the baby’s clinical presentation / indications. Our test is in compliance with ACMG guidelines3 .

Simplified

icon

Results are provided directly to your pediatrician or health-care provider with clear follow-up recommendations. This test can induce a more complex follow-up testing for affected infants.

icon iconIn our reports we target the following conditions:

Cardiovascular conditions, including

  • Alagille syndrome 1
  • Glycogen storage disease, type II

Endocrine conditions, including

  • Corticosterone methyloxidase
    deficiency
  • Familial hyperinsulinism
  • Hyperinsulinism-hyperammonemia
    syndrome

Hepatic conditions, including

  • Acute infantile liver failure
  • Gilbert syndrome
  • Glycogen storage disease, type VI

Immunodeficiencies, including

  • Adenosine deaminase deficiency
  • Chronic granulomatous disease
  • Severe combined immunodeficiency

Hematologic disorders, including

  • Factor IX deficiency
  • Hemolytic anemia
  • Spherocytosis, type 1

Neurological conditions, including

  • Segawa syndrome
  • Spinal muscular atrophy

Metabolic disorders, including

  • Cystinosis
  • Hereditary fructose intolerance
  • Mucopolysaccharidosis, type VI

Renal conditions, including

  • Alport syndrome
  • Distal renal tubular acidosis
  • Primary hyperoxaluria, type 2

Skeletal disorders, including

  • Hypophosphatasia
  • Marfan syndrome
  • Osteopetrosis 1

Pulmonary disorders, including

  • Cystic fibrosis

icon icon Contact your local SZA Longevity representative for more information or
you can send your queries to info@szalongevity.com

icon icon 1- Birth Defects. Retrieved January 17, 2023 from https://www.who.int/news-room/fact-sheets/detail/birth-defects
2- Wright C.F., McRae J.F., Clayton S. et al. Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders. Genet Med 20, 1216–1223 (2018).
3-Manickam K., McClain M.R., Demmer L.A. et al. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics. Genet Med 23, 2029-2037 (2021).